Insulin resistance and HCV virologic response to peg-interferons (Peg-IFN) with ribavirin (RBV) in HIV/HCV co-infected patients.
Donato, C
Insulin resistance and HCV virologic response to peg-interferons (Peg-IFN) with ribavirin (RBV) in HIV/HCV co-infected patients. [electronic resource] - Journal of hepatology Feb 2010 - 306-7 p. digital
Publication Type: Letter; Comment
1600-0641
10.1016/j.jhep.2009.10.028 doi
Adult
Antiviral Agents--therapeutic use
Female
HIV Infections--complications
Hepatitis C--complications
Humans
Insulin Resistance
Interferon alpha-2
Interferon-alpha--therapeutic use
Male
Polyethylene Glycols--therapeutic use
Recombinant Proteins
Retrospective Studies
Ribavirin--therapeutic use
Treatment Outcome
Insulin resistance and HCV virologic response to peg-interferons (Peg-IFN) with ribavirin (RBV) in HIV/HCV co-infected patients. [electronic resource] - Journal of hepatology Feb 2010 - 306-7 p. digital
Publication Type: Letter; Comment
1600-0641
10.1016/j.jhep.2009.10.028 doi
Adult
Antiviral Agents--therapeutic use
Female
HIV Infections--complications
Hepatitis C--complications
Humans
Insulin Resistance
Interferon alpha-2
Interferon-alpha--therapeutic use
Male
Polyethylene Glycols--therapeutic use
Recombinant Proteins
Retrospective Studies
Ribavirin--therapeutic use
Treatment Outcome